Works matching IS 03065251 AND DT 2021 AND VI 87 AND IP 10


Results: 42
    1

    Issue highlights.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3637, doi. 10.1111/bcp.15082
    Publication type:
    Article
    2
    3

    Clinical treatment for hepatitis C reverses CYP2C19 inhibition.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 4013, doi. 10.1111/bcp.14829
    By:
    • Pippa, Leandro Francisco;
    • Vieira, Carolina Pinto;
    • Caris, Juciene Aparecida;
    • Rocha, Adriana;
    • Garcia, Camile Prates;
    • Rezende, Rosamar Eulira Fontes;
    • Lanchote, Vera Lucia
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Zolpidem: A masked hero. A reply to ZORRO study.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 4040, doi. 10.1111/bcp.14820
    By:
    • Lugoboni, Fabio;
    • Casari, Rebecca;
    • Fusina, Francesca;
    • Zamboni, Lorenzo
    Publication type:
    Article
    10
    11
    12
    13

    Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3949, doi. 10.1111/bcp.14816
    By:
    • Gillon, Jean‐Yves;
    • Dennison, Jeremy;
    • van den Berg, Frans;
    • Delhomme, Sophie;
    • Dequatre Cheeseman, Karen;
    • Peña Rossi, Claudia;
    • Strub Wourgaft, Nathalie;
    • Specht, Sabine;
    • Pedrique, Belén;
    • Monnot, Frédéric;
    • Skrabs, Susanne;
    • Rodriguez, Maria‐Luisa;
    • Stass, Heino
    Publication type:
    Article
    14
    15
    16

    Adverse events of recreational cannabis use reported to the French addictovigilance network (2012–2017).

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3925, doi. 10.1111/bcp.14812
    By:
    • Bouquet, Emilie;
    • Pain, Stéphanie;
    • Eiden, Céline;
    • Jouanjus, Emilie;
    • Richard, Nathalie;
    • Fauconneau, Bernard;
    • Pérault‐Pochat, Marie‐Christine;
    • Batisse, Anne;
    • Carton, Louise;
    • Chevalier, Cécile;
    • Daveluy, Amélie;
    • Fournier‐Choma, Christine;
    • Guerlais, Marylène;
    • Le Boisselier, Reynald;
    • Pochard, Liselotte;
    • Revol, Bruno;
    • Tournebize, Juliana
    Publication type:
    Article
    17
    18
    19
    20

    Achievements and challenges of the Sakigake designation system in Japan.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 4027, doi. 10.1111/bcp.14807
    By:
    • Tanaka, Mototsugu;
    • Idei, Mayumi;
    • Sakaguchi, Hiroshi;
    • Kato, Ryosuke;
    • Sato, Daisuke;
    • Sawanobori, Kenji;
    • Kawarasaki, Shuichi;
    • Hata, Toshiyuki;
    • Yoshizaki, Asako;
    • Nakamura, Miki;
    • Ikuma, Mutsuhiro
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3766, doi. 10.1111/bcp.14784
    By:
    • Hoertel, Nicolas;
    • Sánchez‐Rico, Marina;
    • Vernet, Raphaël;
    • Beeker, Nathanaël;
    • Neuraz, Antoine;
    • Alvarado, Jesús M.;
    • Daniel, Christel;
    • Paris, Nicolas;
    • Gramfort, Alexandre;
    • Lemaitre, Guillaume;
    • Salamanca, Elisa;
    • Bernaux, Mélodie;
    • Bellamine, Ali;
    • Burgun, Anita;
    • Limosin, Frédéric
    Publication type:
    Article
    39
    40
    41
    42

    Issue Information.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3635, doi. 10.1111/bcp.14384
    Publication type:
    Article